Immune-related adverse events in the treatment of Hodgkin lymphoma with immune checkpoint inhibitors. Argnani L, Stefoni V, Casadei B, Pelusi C, et al. Br J Haematol 2026 Feb 26. doi: 10.1111/bjh.70402.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Argnani L, Stefoni V, Casadei B, Pelusi C, et al. Immune-related adverse events in the treatment of Hodgkin lymphoma with immune checkpoint inhibitors. Br J Haematol 2026 Feb 26. doi: 10.1111/bjh.70402.
PMID: 41744197